← All indications
Skin Diseases, Infectious
Skin diseases caused by bacteria, fungi, parasites, or viruses.
Subtype terms (6)
More specific conditions that are subtypes of Skin Diseases, Infectious in the MeSH hierarchy.
- Cellulitis
33 drugs (29 approved, 4 experimental)
- Dermatomycoses
7 drugs (5 approved, 2 experimental)
- Paronychia
7 drugs (4 approved, 3 experimental)
- Skin Diseases, Bacterial
42 drugs (33 approved, 9 experimental)
- Skin Diseases, Parasitic
- Skin Diseases, Viral
1 drug approved
Drugs by status
Approved for this indication (16)
Phase 4 trials (10)
Phase 3 trials (10)
Phase 2 trials (2)
Organizations
Organization Involved with Phase 4 Indications (14)
- Forest Laboratories
- Novartis
- Allergan
- Ascension Health
- Henry Ford Health System
- Johns Hopkins University
- St. John Providence Health System
- Wayne State University
- St. Louis University
- University of Cincinnati
- Washington University in St. Louis
- University of Texas, San Antonio
- Thrasher Research Fund
- Michigan Ear Institute
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (14)
- Targanta
- CrystalGenomics, Inc.
- Lytix Biopharma AS
- Protez Pharmaceuticals
- Verrica Pharmaceuticals Inc.
- National Institute of Allergy and Infectious Diseases (NIAID)
- Trius Therapeutics
- St. George Albert Clinic Zeged University Hospital
- Indiana Clinical Trials Center
- Paidion Research, Inc
- Instat services
- BioClinica, Inc.
- Innovation Pharmaceuticals
- Wake Dermatology
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (8)